Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Auction 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about LSD Therapy
Recent news which mentions LSD Therapy
Can LSD Therapy Calm Anxious Dogs? First-Of-Its-Kind Study Uncovers New Possibilities
September 27, 2024
Tickers
DOGS
PETS
Tags
Psychedelics Research
LSD dogs
Psychedelics
From
Benzinga
Podcast: LSD 'Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics' Says MindMed's R. Barrow
March 27, 2024
Tickers
MNMD
NEWS
Tags
Cannabis
Market News
Psychedelic/Assisted Therapies
From
Benzinga
MindMeds Systematic Biotech Approach With New FDA Therapy Designation, 12-Week Clinical Data, Plus Expected $175M Proceeds
March 08, 2024
Tickers
MNMD
NEWS
Tags
Global
Psychedelic/Assisted Therapies
Price Target Increases
From
Benzinga
MindMed Receives FDA 'Breakthrough Therapy' Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials
March 07, 2024
Tickers
CMPS
MNMD
NEWS
Tags
LSD Therapy
FDA
Biotech
From
Benzinga
MindMed's 2023 Financial Results And Business Recap: Milestones Amid Rising Expenses
February 28, 2024
Tickers
MNMD
Tags
Psychedelics Financing
MNMD
Management
From
Benzinga
MindMed's 2024 Plans: Anxiety Treatment Stands, LSD Microdosing For ADHD Will Be Discontinued
January 11, 2024
Tickers
MNMD
NEWS
Tags
Benzinga
Psychedelics
Generalized Anxiety Disorder
From
Benzinga
Federico Fellini's LSD Journey: How It Inspired Some Of The Greatest Films Of All Time
August 23, 2023
Tags
Federico Fellini
Market News
Markets
From
Benzinga
BetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD Derivatives
June 28, 2023
Tickers
BETRF
PHRRF
Tags
Guidance
Psychedelic/Assisted Therapies
Market News
From
Benzinga
Numinus' Clinical Arm To Lead Enrollment Site For MindMed's Phase 2b LSD Study
June 05, 2023
Tickers
CMPS
MNMD
NUMIF
Tags
NUMIF
Penny Stocks
MNMD
From
Benzinga
MindMed And FCM Holdings' Dispute Over Clinical Path Forward Deepens
May 30, 2023
Tickers
MNMD
Tags
Proxy fight
Benzinga
MNMD
From
Benzinga
MindMed's LSD Study For Anxiety Treatment Enrolls And Doses 100 Participants, More Expected
May 19, 2023
Tickers
MNMD
Tags
Penny Stocks
Generalized Anxiety Disorder
MNMD
From
Benzinga
MindMed Reports Q1 2023 Financial Results, Business Highlights, Upcoming Elections
May 05, 2023
Tickers
MNMD
Tags
Benzinga
MNMD
News
From
Benzinga
80 Years Post-Discovery, LSD Shows Significant Potential For Major Depression In Advanced Clinical Trial
April 17, 2023
Tickers
MNMD
Tags
Management
Health Care
University Hospital Basel
From
Benzinga
LSD's Impact On The Body's Cannabinoid And Microorganisms Systems, New Study Sheds Light
January 13, 2023
Tags
Benzinga
Psychedelics
endocannabinoid system
From
Benzinga
Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More
November 29, 2022
Tickers
AWKNF
CMND
CMPS
PSIL
Tags
Psychedelics
Benzinga
PSIL
From
Benzinga
MindMed's Q3 2022 Financials & Business, Setting The Stage For Phase 3 Trials
November 11, 2022
Tickers
MNMD
Tags
Psychedelics
clinical trials
Robert Barrow
From
Benzinga
LSD Microdosing Yields Positive Outcomes In Phase 1 Study, More Trials On Depression & Existential Distress
November 04, 2022
Tickers
BLRZF
Tags
Benzinga
Microdosing
Psychedelics
From
Benzinga
Psychedelics Companies And IPs: An Extended Patent Application To Protect Multiple LSD Derivatives
September 27, 2022
Tickers
BETRF
Tags
BETRF
Penny Stocks
U/S/ Patent and Trademark Office
From
Benzinga
This LSD Phase 2 Clinical Trial Is Showing Positive Results For Treatment Of Generalized Anxiety
September 08, 2022
Tickers
MNMD
Tags
Benzinga
Biological Psychiatry
Generalized
From
Benzinga
Connecting To Nature Through Psychedelics
April 17, 2022
Tickers
TECH
Tags
LSD Therapy
Markets
Cannabis
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.